Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cells. [electronic resource] by
- Allen, Wendy L
- Turkington, Richard C
- Stevenson, Leanne
- Carson, Gail
- Coyle, Vicky M
- Hector, Suzanne
- Dunne, Philip
- Van Schaeybroeck, Sandra
- Longley, Daniel B
- Johnston, Patrick G
Producer: 20121217
In:
Molecular cancer therapeutics vol. 11
Availability: No items available.
|
|
|
10.
|
Clinical determinants of response to irinotecan-based therapy derived from cell line models. [electronic resource] by
- Allen, Wendy L
- Coyle, Vicky M
- Jithesh, Puthen V
- Proutski, Irina
- Stevenson, Leanne
- Fenning, Cathy
- Longley, Daniel B
- Wilson, Richard H
- Gordon, Michael
- Lenz, Heinz-Josef
- Johnston, Patrick G
Producer: 20081216
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 14
Availability: No items available.
|
|
|
11.
|
A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancer. [electronic resource] by
- Allen, Wendy L
- Stevenson, Leanne
- Coyle, Vicky M
- Jithesh, Puthen V
- Proutski, Irina
- Carson, Gail
- Gordon, Michael A
- Lenz, Heinz-Josef D
- Van Schaeybroeck, Sandra
- Longley, Daniel B
- Johnston, Patrick G
Producer: 20120629
In:
Molecular cancer therapeutics vol. 11
Availability: No items available.
|
|
|
12.
|
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424. [electronic resource] by
- Woodcock, Victoria K
- Clive, Sally
- Wilson, Richard H
- Coyle, Vicky M
- Stratford, Michael R L
- Folkes, Lisa K
- Eastell, Richard
- Barton, Claire
- Jones, Paul
- Kazmi-Stokes, Shamim
- Turner, Helen
- Halford, Sarah
- Harris, Adrian L
- Middleton, Mark R
Producer: 20190415
In:
British journal of cancer vol. 118
Availability: No items available.
|
|
|
13.
|
Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival. [electronic resource] by
- Alderdice, Matthew
- Dunne, Philip D
- Cole, Aidan J
- O'Reilly, Paul G
- McArt, Darragh G
- Bingham, Vicky
- Fuchs, Marc-Aurel
- McQuaid, Stephen
- Loughrey, Maurice B
- Murray, Graeme I
- Samuel, Leslie M
- Lawler, Mark
- Wilson, Richard H
- Salto-Tellez, Manuel
- Coyle, Vicky M
Producer: 20180521
In:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 30
Availability: No items available.
|
|
|
14.
|
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours. [electronic resource] by
- Jamieson, David
- Griffin, Melanie J
- Sludden, Julieann
- Drew, Yvette
- Cresti, Nicola
- Swales, Karen
- Merriman, Mark
- Allen, Rodger
- Bevan, Paul
- Buerkle, Markus
- Mala, Carola
- Coyle, Vicky
- Rodgers, Lisa
- Dean, Emma
- Greystoke, Alastair
- Banerji, Udai
- Wilson, Richard H
- Evans, T R Jeffery
- Anthoney, Alan
- Ranson, Malcolm
- Boddy, Alan V
- Plummer, Ruth
Producer: 20170808
In:
European journal of cancer (Oxford, England : 1990) vol. 68
Availability: No items available.
|